[Infections caused by coagulase-negative Staphylococci in immunocompromised patients]. 1986

G Peters, and F Schumacher-Perdreau, and G Pulverer

Coagulase-negative staphylococci are important members of the normal aerobic microflora of human skin and mucous membranes. Normally they are not pathogenic for men. But the increase in patients with implanted plastic foreign bodies or intravascular catheters had led to a dramatic change. In these patients, coagulase-negative staphylococci are the predominant organisms causing septicemia. Special pathomechanisms are involved in the colonization of polymers by staphylococci leading to a "plastic infection". Intravascular catheters are also important factors in the origin of septicemia in premature neonates and in patients with malignant diseases, especially under cytostatic therapy. Premature or suppressed opsonophagocytosis mechanisms are responsible for the origin and maintainance of septicemia.

UI MeSH Term Description Entries
D007108 Immune Tolerance The specific failure of a normally responsive individual to make an immune response to a known antigen. It results from previous contact with the antigen by an immunologically immature individual (fetus or neonate) or by an adult exposed to extreme high-dose or low-dose antigen, or by exposure to radiation, antimetabolites, antilymphocytic serum, etc. Immunosuppression (Physiology),Immunosuppressions (Physiology),Tolerance, Immune
D007231 Infant, Newborn An infant during the first 28 days after birth. Neonate,Newborns,Infants, Newborn,Neonates,Newborn,Newborn Infant,Newborn Infants
D007234 Infant, Premature A human infant born before 37 weeks of GESTATION. Neonatal Prematurity,Premature Infants,Preterm Infants,Infant, Preterm,Infants, Premature,Infants, Preterm,Premature Infant,Prematurity, Neonatal,Preterm Infant
D007970 Leukopenia A decrease in the number of LEUKOCYTES in a blood sample below the normal range (LEUKOCYTE COUNT less than 4000). Leukocytopenia,Leukocytopenias,Leukopenias
D010969 Plastics Polymeric materials (usually organic) of large molecular weight which can be shaped by flow. Plastic usually refers to the final product with fillers, plasticizers, pigments, and stabilizers included (versus the resin, the homogeneous polymeric starting material). (McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed) Plastic
D002404 Catheterization Use or insertion of a tubular device into a duct, blood vessel, hollow organ, or body cavity for injecting or withdrawing fluids for diagnostic or therapeutic purposes. It differs from INTUBATION in that the tube here is used to restore or maintain patency in obstructions. Cannulation,Cannulations,Catheterizations
D003030 Coagulase Enzymes that cause coagulation in plasma by forming a complex with human PROTHROMBIN. Coagulases are produced by certain STAPHYLOCOCCUS and YERSINIA PESTIS. Staphylococci produce two types of coagulase: Staphylocoagulase, a free coagulase that produces true clotting of plasma, and Staphylococcal clumping factor, a bound coagulase in the cell wall that induces clumping of cells in the presence of fibrinogen. Staphylocoagulase,Staphylococcal Clumping Factor,Clumping Factor (Staphylococcal),Staphylococcus aureus clone pSCa2 of Coagulase,Staphylococcus aureus strain 213 of Coagulase,Staphylococcus aureus strain 8325-4 of Coagulase,Clumping Factor, Staphylococcal,Factor, Staphylococcal Clumping,Staphylococcus aureus strain 8325 4 of Coagulase
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000970 Antineoplastic Agents Substances that inhibit or prevent the proliferation of NEOPLASMS. Anticancer Agent,Antineoplastic,Antineoplastic Agent,Antineoplastic Drug,Antitumor Agent,Antitumor Drug,Cancer Chemotherapy Agent,Cancer Chemotherapy Drug,Anticancer Agents,Antineoplastic Drugs,Antineoplastics,Antitumor Agents,Antitumor Drugs,Cancer Chemotherapy Agents,Cancer Chemotherapy Drugs,Chemotherapeutic Anticancer Agents,Chemotherapeutic Anticancer Drug,Agent, Anticancer,Agent, Antineoplastic,Agent, Antitumor,Agent, Cancer Chemotherapy,Agents, Anticancer,Agents, Antineoplastic,Agents, Antitumor,Agents, Cancer Chemotherapy,Agents, Chemotherapeutic Anticancer,Chemotherapy Agent, Cancer,Chemotherapy Agents, Cancer,Chemotherapy Drug, Cancer,Chemotherapy Drugs, Cancer,Drug, Antineoplastic,Drug, Antitumor,Drug, Cancer Chemotherapy,Drug, Chemotherapeutic Anticancer,Drugs, Antineoplastic,Drugs, Antitumor,Drugs, Cancer Chemotherapy
D013203 Staphylococcal Infections Infections with bacteria of the genus STAPHYLOCOCCUS. Infections, Staphylococcal,Staphylococcus aureus Infection,Staphylococcal Infection,Staphylococcus aureus Infections

Related Publications

G Peters, and F Schumacher-Perdreau, and G Pulverer
October 1987, Pediatria polska,
G Peters, and F Schumacher-Perdreau, and G Pulverer
November 1987, The Pediatric infectious disease journal,
G Peters, and F Schumacher-Perdreau, and G Pulverer
August 1979, The Journal of pediatrics,
G Peters, and F Schumacher-Perdreau, and G Pulverer
January 1979, Infection,
G Peters, and F Schumacher-Perdreau, and G Pulverer
June 1968, Mayo Clinic proceedings,
G Peters, and F Schumacher-Perdreau, and G Pulverer
October 1961, Nordisk medicin,
G Peters, and F Schumacher-Perdreau, and G Pulverer
April 1981, Harefuah,
G Peters, and F Schumacher-Perdreau, and G Pulverer
June 1990, Missouri medicine,
G Peters, and F Schumacher-Perdreau, and G Pulverer
January 1988, The Journal of antimicrobial chemotherapy,
G Peters, and F Schumacher-Perdreau, and G Pulverer
January 1994, Acta microbiologica et immunologica Hungarica,
Copied contents to your clipboard!